Current liabilities increased 70.2%
Current liabilities changed +70.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +70.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +43.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -649 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed -30.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +18.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +673.9% from the comparable as-filed period.
Revenue changed +122.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +512.7% from the comparable as-filed period.
Operating margin changed +2477 basis points from the comparable as-filed period.
Cash & equivalents changed +49.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory / revenue changed -3794 basis points from the comparable as-filed period.
Gross profit changed +128.1% from the comparable as-filed period.
SBC / revenue changed -265 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed +117.8% from the comparable as-filed period.
Operating income changed +1220.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
R&D / revenue changed -1079 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +115 basis points from the comparable as-filed period.
Research & development changed +22.9% from the comparable as-filed period.
Capital expenditure changed +104.6% from the comparable as-filed period.
Free-cash-flow margin changed +883 basis points from the comparable as-filed period.
Operating cash-flow margin changed +871 basis points from the comparable as-filed period.
Total assets changed +17.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +15.6% from the comparable as-filed period.
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes. This reverses 7 consecutive comparable moves in the opposite direction.
Capex / revenue changed -11 basis points from the comparable as-filed period.
Stock-based compensation changed -0.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.